{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:41:47Z","timestamp":1772109707592,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12630-014-0262-2","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T12:41:07Z","timestamp":1415968867000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review","Pr\u00e9vention des thromboembolies veineuses dans le cadre de la R\u00e9cup\u00e9ration rapide apr\u00e8s la chirurgie (RRAC): une synth\u00e8se bas\u00e9e sur les donn\u00e9es probantes"],"prefix":"10.1007","volume":"62","author":[{"name":"on behalf of Thrombosis Canada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin R.","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal E.","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","unstructured":"Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107(23 Suppl 1: I22-30.","DOI":"10.1161\/01.CIR.0000078464.82671.78"},{"issue":"2 Suppl.","key":"262_CR2","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Y Falck-Ytter","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl.): e278S-325S.","journal-title":"Chest"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.thromres.2012.07.011","volume":"130","author":"PD Stein","year":"2012","unstructured":"Stein PD, Matta F, Alrifai A, Rahman A. Trends in case fatality rate in pulmonary embolism according to stability and treatment. Thromb Res 2012; 130: 841-6.","journal-title":"Thromb Res"},{"issue":"2 Suppl.","key":"262_CR4","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl.): e227S-77S.","journal-title":"Chest"},{"issue":"6 Suppl.","key":"262_CR5","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133(6 Suppl.): 381S-453S.","journal-title":"Chest"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1345\/aph.1R247","volume":"47","author":"GD Pebanco","year":"2013","unstructured":"Pebanco GD, Kaiser SA, Haines ST. New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis. Ann Pharmacother 2013; 47: 605-16.","journal-title":"Ann Pharmacother"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1213\/01.ane.0000237267.75543.59","volume":"103","author":"WJ Mauermann","year":"2006","unstructured":"Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 2006; 103: 1018-25.","journal-title":"Anesth Analg"},{"issue":"Suppl 3","key":"262_CR8","first-page":"304","volume":"17","author":"JA Caprini","year":"1991","unstructured":"Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991; 17(Suppl 3): 304-12.","journal-title":"Semin Thromb Hemost"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","volume":"5","author":"BI Eriksson","year":"2007","unstructured":"Eriksson BI, Dahl OE, Rosencher N, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5: 2178-85.","journal-title":"J Thromb Haemost"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","volume":"370","author":"BI Eriksson","year":"2007","unstructured":"Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007; 370: 949-56.","journal-title":"Lancet"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMc081524","volume":"359","author":"H Cate ten","year":"2008","unstructured":"ten Cate H, Hamulyak K. Rivaroxaban for thromboprophylaxis. N Engl J Med 2008; 359: 2174-6.","journal-title":"N Engl J Med"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","volume":"373","author":"AG Turpie","year":"2009","unstructured":"Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373: 1673-80.","journal-title":"Lancet"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1302\/0301-620X.91B5.21691","volume":"91","author":"BI Eriksson","year":"2009","unstructured":"Eriksson BI, Kakkar AK, Turpie AG, et al. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br 2009; 91: 636-44.","journal-title":"J Bone Joint Surg Br"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1538-7836.2007.02764.x","volume":"5","author":"MR Lassen","year":"2007","unstructured":"Lassen MR, Davidson BL, Gallus A, Pineo G. J Ansell, Deitchman D. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. J Thromb Haemost 2007; 5: 2368-75.","journal-title":"J Thromb Haemost"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMc091817","volume":"361","author":"A Gomez-Outes","year":"2009","unstructured":"Gomez-Outes A, Suarez-Gea ML, Pozo-Hernandez C. Apixaban or enoxaparin for thromboprophylaxis. N Engl J Med 2009; 361: 2100-1.","journal-title":"N Engl J Med"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc1100733","volume":"364","author":"SS Jameson","year":"2011","unstructured":"Jameson SS, Sanders RD, Reed MR. Apixaban vs. enoxaparin after hip replacement. N Engl J Med 2011; 364: 1177.","journal-title":"N Engl J Med"},{"key":"262_CR17","doi-asserted-by":"crossref","unstructured":"Anonymous. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302.","DOI":"10.1016\/S0140-6736(00)02110-3"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","volume":"158","author":"DR Anderson","year":"2013","unstructured":"Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 2013; 158: 800-6.","journal-title":"Ann Intern Med"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/archinte.162.13.1451","volume":"162","author":"N Strebel","year":"2002","unstructured":"Strebel N, Prins M, Agnelli G, Buller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162: 1451-6.","journal-title":"Arch Intern Med"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","volume":"35","author":"TT Horlocker","year":"2010","unstructured":"Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010; 35: 64-101.","journal-title":"Reg Anesth Pain Med"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","volume":"27","author":"W Gogarten","year":"2010","unstructured":"Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27: 999-1015.","journal-title":"Eur J Anaesthesiol"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0002-9343(83)90805-7","volume":"74","author":"SZ Goldhaber","year":"1983","unstructured":"Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983; 74: 1023-8.","journal-title":"Am J Med"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1586\/erc.10.160","volume":"8","author":"AL Freeman","year":"2010","unstructured":"Freeman AL, Pendleton RC, Rondina MT. Prevention of venous thromboembolism in obesity. Exp Rev Cardiovasc Ther 2010; 8: 1711-21.","journal-title":"Exp Rev Cardiovasc Ther"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","volume":"355","author":"GM Arepally","year":"2006","unstructured":"Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. N Engl J Med 2006; 355: 809-17.","journal-title":"N Engl J Med"},{"key":"262_CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","volume":"332","author":"AT Cohen","year":"2006","unstructured":"Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332: 325-9.","journal-title":"BMJ"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa011100","volume":"345","author":"BI Eriksson","year":"2001","unstructured":"Eriksson BI, Bauer KA, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345: 1298-304.","journal-title":"N Engl J Med"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(02)08648-8","volume":"359","author":"AG Turpie","year":"2002","unstructured":"Turpie AG, Bauer KA, Eriksson BI, Lassen MR; PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002; 359: 1721-6.","journal-title":"Lancet"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)08652-X","volume":"359","author":"MR Lassen","year":"2002","unstructured":"Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002; 359: 1715-20.","journal-title":"Lancet"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa011099","volume":"345","author":"KA Bauer","year":"2001","unstructured":"Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345: 1305-10.","journal-title":"N Engl J Med"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/bjs.5154","volume":"92","author":"G Agnelli","year":"2005","unstructured":"Agnelli G, Bergqvist D. Cohen AT, Gallus AS, Gent M; PEGASUS Investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005; 92: 1212-20.","journal-title":"Br J Surg"},{"key":"262_CR31","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1538-7836.2011.04487.x","volume":"9","author":"TE Warkentin","year":"2011","unstructured":"Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thrombosis Haemost 2011; 9: 2389-96.","journal-title":"J Thrombosis Haemost"},{"key":"262_CR32","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.109.872630","volume":"120","author":"JW Eikelboom","year":"2009","unstructured":"Eikelboom JW, Quinlan DJ, O\u2019Donnell M. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. Circulation 2009; 120: 2006-11.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"262_CR33","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative Management of Antithrombotic Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(Suppl 2): e326S-50S.","journal-title":"Chest"},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","volume":"370","author":"PJ Devereaux","year":"2014","unstructured":"Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494-503.","journal-title":"N Engl J Med"},{"key":"262_CR35","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jth.12282","volume":"11","author":"AC Spyropoulos","year":"2013","unstructured":"Spyropoulos AC, Albaladejo P, Godier A, et al. Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1593-6.","journal-title":"J Thromb Haemost"},{"key":"262_CR36","doi-asserted-by":"crossref","unstructured":"Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol 2011; 27 Suppl A: S1-59.","DOI":"10.1016\/j.cjca.2010.12.015"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-014-0262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-014-0262-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-014-0262-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T06:56:30Z","timestamp":1566024990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-014-0262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s12630-014-0262-2","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}